Charles Schwab Investment Management Inc Alnylam Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 487,348 shares of ALNY stock, worth $119 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
487,348
Previous 470,592
3.56%
Holding current value
$119 Million
Previous $114 Million
17.23%
% of portfolio
0.03%
Previous 0.02%
Shares
29 transactions
Others Institutions Holding ALNY
# of Institutions
643Shares Held
109MCall Options Held
1.28MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA16.5MShares$4.02 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.6MShares$3.07 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.32 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.24MShares$1.28 Billion0.31% of portfolio
-
Wellington Management Group LLP Boston, MA4.95MShares$1.2 Billion0.24% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $29.9B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...